(Q54302143)

27 May 2018

title

Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. (English)

1 reference

27 May 2018

1 reference

Heejeong Lee

1

1 reference

27 May 2018

Hyun Joo Choi

2

1 reference

27 May 2018

Chang Suk Kang

3

1 reference

27 May 2018

Hee Jin Lee

4

1 reference

27 May 2018

Weon Sun Lee

5

1 reference

27 May 2018

Chul Soo Park

6

1 reference

27 May 2018

publication date

6 July 2012

1 reference

27 May 2018

published in

Modern Pathology

1 reference

27 May 2018

volume

25

1 reference

27 May 2018

issue

11

1 reference

27 May 2018

page(s)

1508-1515

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.111

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Nationwide cancer incidence in Korea, 2003-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Endometrial hyperplasia and the risk of progression to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Precursors of endometrial and ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNA signature and regulatory functions in the endometrium during normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNAs in tumorigenesis: a primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

miRNA genetic alterations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNA in cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Mechanisms of microRNA deregulation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Comprehensive miRNA profiling of surgically staged endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNA signatures differentiate uterine cancer tumor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

The microRNA-200 family is upregulated in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

miR-129 regulates cell proliferation by downregulating Cdk6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Modulation of mismatch repair and genomic stability by miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Involution of PTEN-null endometrial glands with progestin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Estrogen Regulation of MicroRNA Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Molecular evidence for differences in endometrium in severe versus mild endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

Small RNAs are raising big expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

inferred from DOI database lookup

7 January 2021

based on heuristic

PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.111

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2012.111

1 reference

27 May 2018

PubMed ID

22766795

1 reference

27 May 2018